In the **biotech** scene, **Keurig Dr Pepper (KDP)** has made headlines with numerous significant updates. Their earnings are anticipated with keen interest and they continue to grow operations in **Spartanburg County**. KDP's insiders purchased US$21.1m of stock, instilling confidence in the market, leading Barclays to raise their price target from $37 to $41. KDP's dividend has also been increased by 7.0%. However, their recent misled claims about K-Cup recyclability resulted in a $1.5M settlement. On the bright side, they have committed to $141M for expanding operations in Spartanburg County. KDP has partnered with **Black Rifle Coffee** for distribution and sustained their commitment towards their 2025 sustainable packaging goals. They've been upgraded by Citi based on their improving U.S. coffee sales. Their intentions to buy Kalil Bottling Assets and confirmations of financial growth through sales and results reaffirm their market strength. However, the closure of their Windsor plant and SEC charges over K-Cups' claims have put them under some scrutiny. Despite this, KDP shares are still experiencing a steady rise.
Keurig Dr Pepper KDP News Analytics from Thu, 29 Feb 2024 08:00:00 GMT to Fri, 11 Oct 2024 15:43:56 GMT -
Rating 5
- Innovation -4
- Information 7
- Rumor 3
